Bank Julius Baer & Co
RGNX icon

Bank Julius Baer & Co’s Regenxbio RGNX Stock Holding History

Bank Julius Baer & Co’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,503
Closed -$170K – 566
2023
Q2 		$170K Sell
8,503
-543
-6% -$10.5K ﹤0.01% 422
2023
Q1 		$171K Sell
9,046
-1,478
-14% -$32.7K ﹤0.01% 447
2022
Q4 		$239K Sell
10,524
-2,633
-20% -$59.5K ﹤0.01% 405
2022
Q3 		$348K Buy
13,157
+1,789
+16% +$53.1K ﹤0.01% 360
2022
Q2 		$281K Sell
11,368
-4,418
-28% -$110K ﹤0.01% 386
2022
Q1 		$524K Sell
15,786
-602
-4% -$16.7K ﹤0.01% 344
2021
Q4 		$536K Buy
16,388
+9,766
+147% +$333K ﹤0.01% 418
2021
Q3 		$278K Sell
6,622
-765
-10% -$27.5K ﹤0.01% 512
2021
Q2 		$287K Sell
7,387
-1,879
-20% -$67.2K ﹤0.01% 525
2021
Q1 		$316K Sell
9,266
-9,914
-52% -$423K ﹤0.01% 507
2020
Q4 		$870K Buy
19,180
+7,370
+62% +$258K 0.01% 375
2020
Q3 		$278K Buy
11,810
+10,474
+784% +$341K ﹤0.01% 463
2020
Q2 		$287K Sell
1,336
-8,446
-86% -$315K ﹤0.01% 421
2020
Q1 		$316K Buy
+9,782
New +$408K 0.01% 363

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank Julius Baer & Co's RGNX Position: Q3 2023 in Review

Bank Julius Baer & Co sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 8,503 shares — an estimated $170K sold.

Bank Julius Baer & Co first reported a position in RGNX in Q1 2020 and held it in 14 quarters. The position peaked at $870K in Q4 2020. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Bank Julius Baer & Co reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 8,503 Regenxbio shares in Q3 2023, an estimated $170K.
  • Bank Julius Baer & Co first reported a position in Regenxbio in Q1 2020 and held it in 14 quarters.
  • Bank Julius Baer & Co's Regenxbio position peaked at $870K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Bank Julius Baer & Co's 13F filing for Q3 2023, filed 13 Nov 2023.